Bioasis Technologies
Prof. Ferdinando Nicoletti is the co-founder of CRESENCE AS, a Member of the Board, Acting CSO. He is a Professor of General Pathology and Immunology, University of Catania (Italy). He serves in the Editorial Boards of several international journals including Antioxidants and Redox Signalling, Basic and Clinical Pharmacology and Toxicology and the European Journal of Pharmacology. He is the Co-founder of GaNiAl Immunotherapeutic Inc. (USA), of Onconox (Copenhagen, Denmark) and AURA Biopharm (Oslo, Norway).
This person is not in any offices
Bioasis Technologies
1 followers
Bioasis is dedicated to delivering hope to patients suffering with neurological diseases and disorders. Our breakthrough science focuses on transporting medicines across the blood-brain barrier, providing a path to hundreds of previously untreatable di...